FR2803519B1 - Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau - Google Patents

Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau

Info

Publication number
FR2803519B1
FR2803519B1 FR0000322A FR0000322A FR2803519B1 FR 2803519 B1 FR2803519 B1 FR 2803519B1 FR 0000322 A FR0000322 A FR 0000322A FR 0000322 A FR0000322 A FR 0000322A FR 2803519 B1 FR2803519 B1 FR 2803519B1
Authority
FR
France
Prior art keywords
papyrace
dehydroepiandrosterone
precursors
derivatives
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0000322A
Other languages
English (en)
Other versions
FR2803519A1 (fr
Inventor
La Charriere Olivier De
Stephanie Nouveau
Francoise Forette
Etienne Emile Baulieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to FR0000322A priority Critical patent/FR2803519B1/fr
Priority to PCT/FR2001/000063 priority patent/WO2001051023A1/fr
Priority to JP2001551447A priority patent/JP2003519648A/ja
Priority to US10/181,001 priority patent/US20030059451A1/en
Priority to EP01907604A priority patent/EP1246604A1/fr
Priority to AU2001235527A priority patent/AU2001235527A1/en
Publication of FR2803519A1 publication Critical patent/FR2803519A1/fr
Application granted granted Critical
Publication of FR2803519B1 publication Critical patent/FR2803519B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
FR0000322A 2000-01-12 2000-01-12 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau Expired - Fee Related FR2803519B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0000322A FR2803519B1 (fr) 2000-01-12 2000-01-12 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau
PCT/FR2001/000063 WO2001051023A1 (fr) 2000-01-12 2001-01-10 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau
JP2001551447A JP2003519648A (ja) 2000-01-12 2001-01-10 皮膚の紙様外見を改善するための、経口投与されるデヒドロエピアンドロステロン、その前駆体および誘導体の使用
US10/181,001 US20030059451A1 (en) 2000-01-12 2001-01-10 Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin
EP01907604A EP1246604A1 (fr) 2000-01-12 2001-01-10 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau
AU2001235527A AU2001235527A1 (en) 2000-01-12 2001-01-10 Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0000322A FR2803519B1 (fr) 2000-01-12 2000-01-12 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau

Publications (2)

Publication Number Publication Date
FR2803519A1 FR2803519A1 (fr) 2001-07-13
FR2803519B1 true FR2803519B1 (fr) 2002-03-22

Family

ID=8845811

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0000322A Expired - Fee Related FR2803519B1 (fr) 2000-01-12 2000-01-12 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau

Country Status (6)

Country Link
US (1) US20030059451A1 (fr)
EP (1) EP1246604A1 (fr)
JP (1) JP2003519648A (fr)
AU (1) AU2001235527A1 (fr)
FR (1) FR2803519B1 (fr)
WO (1) WO2001051023A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803751B1 (fr) * 2000-01-17 2004-03-12 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe
US9839604B1 (en) * 2014-11-21 2017-12-12 Parham Tabibian, MD, Inc. Composition for an anti-aging treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
JPS63267722A (ja) * 1987-04-27 1988-11-04 Daiichi Yakuhin Sangyo Kk 抗肥満症剤
JPS6440428A (en) * 1987-08-07 1989-02-10 Daiichi Yakuhin Sangyo Kk Antihyperlipemia
IE900306A1 (en) * 1990-01-29 1991-07-31 Elan Corp Agent for use in the prevention, control or reversal of¹hypertension
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
JPH07258091A (ja) * 1994-03-17 1995-10-09 Kyowa Hakko Kogyo Co Ltd アトピー性皮膚炎治療剤
JP2698865B2 (ja) * 1994-08-08 1998-01-19 仲昭 大澤 筋緊張性ジストロフィー症治療剤
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
EP0908183A1 (fr) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Déhydroépiandrostérone ou ses dérivés pour augmenter la quantité d'acide hyaluronique dans la peau

Also Published As

Publication number Publication date
US20030059451A1 (en) 2003-03-27
EP1246604A1 (fr) 2002-10-09
JP2003519648A (ja) 2003-06-24
WO2001051023A1 (fr) 2001-07-19
AU2001235527A1 (en) 2001-07-24
FR2803519A1 (fr) 2001-07-13

Similar Documents

Publication Publication Date Title
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DE60027984D1 (de) Damenbinde
EE05109B1 (et) Sulfoonamiidi derivaadid, nende kasutamine meditsiinis ning meetod nende valmistamiseks
ATE342708T1 (de) Kosmetiktuch
DE60027251D1 (de) Damenbinde
DE69836464D1 (de) Orale Zusammensetzung für die Behandlung von übelriechendem Atem
NO20016423D0 (no) Tampong for kvinnehygiene, og fremgangsmåte og innretning for dens fremstilling
DE60034541D1 (de) Damenbinde
FR2810540B1 (fr) Nouvelles preparations cosmetiques ou hygieniques sous forme de dispersion
DE60023003D1 (de) Haarbehandlungsmittel
FR2803519B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau
FR2806301B1 (fr) Composition a base de sphingolipide et de beta-hydroxy-acide utilisable par voie topique pour les soins de la peau
FR2780886B1 (fr) Composition auto-hydratante pour la peau
ITMI992048A0 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabi cicloalcani
FR2803751B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
FR2803518B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives metaboliques comme regulateurs de la pigmentation
FR2826578B1 (fr) Composition cosmetique chauffante, et son utilisation pour le nettoyage de la peau
FR2792222B1 (fr) Agent emulsifiant, son procede de preparation et son utilisation pour la preparation de compositions cosmetiques, dermatologiques ou pharmacologiques
IT1317331B1 (it) Procedimento per la realizzazione di plantari anatomici perfezionati emezzi per l'attuazione del procedimento.
ES1042364Y (es) "pañal perfeccionado".
ITRM20000149V0 (it) Articolo per l'igiene orale.
UA4040S (uk) Півпальто жіноче хутрове
UA4024S (uk) Півпальто жіноче хутрове

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130930